共 14 条
[1]
Theinvivopharmacologicalprofile ofCS747,anovelantiplateletagentwithplateletADPreceptorantagonist properties. SugidachiA,AsaiF,OgawaT,etal. British Journal of Pharmacology . 2000
[2]
Impactofanginaclassoninhibition ofplateletaggregationfollowingclopidogrelloadinginpatientsundergoing coronaryintervention:doweneedmoreaggressivedosingregimensinun stableangina. SofferD,MoussaI,HarjaiKJ,etal. CatheterCardiovascInterv . 2003
[3]
Lackofadverseclopidogrel atorv astatinclinicalinteractionfromsecondaryanalysisofarandomized,place bo controlledclopidogreltrial. SawJ,SteinhublSR,BergerPB,etal. Circulation . 2003
[4]
Atorvastatinreducestheability ofclopidogreltoinhibitplateletaggregation:anewdrug drug interaction. LauWC,WaskellLA,WatkinsPB,etal. Circulation . 2003
[5]
Themetabolismofclopidogreliscatalyzedby humancytochromeP4503Aandisinhibitedbyatorvastatin. ClarkeTA,WaskellLA. Drug Metabolism and Disposition . 2003
[6]
Prevalenceofclopidogrelnon respond ersamongpatientswithstableanginapectorisscheduledforelectivecoro narystentplacement. MullerI,BestaF,SchulzC,etal. Thrombosis and Haemostasis . 2003
[7]
Plateletfunctionassays. RandML,LeungR,PackhamMA. Transfus ApheresisSci . 2003
[8]
Clopidogrelforcoronarystenting:responsevariability,drugresistance,andtheeffectofpretreatmentplatelet reactivity. GurbelPA,BlidenKP,HiattBL,etal. Circulation . 2003
[9]
Clopidogrelresistanceisasso ciatedwithincreasedriskofrecurrentatherothromboticeventsinpatients withacutemyocardialinfarction. MatetzkyS,ShenkmanB,GuettaV,etal. Circulation . 2004
[10]
TheP2Y12receptorasatherapeutictargetincardiovasculardis ease. StoreyRF. Platelets . 2001